India's Pharmaceutical Exports

Country Profile

Seychelles

Seychelles is a developing market for Indian pharmaceuticals — $4.39M in FY 2025–26, with 2.6× growth over the past decade. Medicines accounts for 90% of shipments, with vaccines contributing $33K. The compound annual growth rate since FY2015 stands at 9.2%.

🇸🇨 $4.39M · 2.6× growth since FY2015 · 9.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$4.39M
Exports FY2025–26 DGCIS
2.6×
Growth FY2015→2026
9.2%
CAGR FY2015→2026
90%
Medicines Share
4
Product Categories Supplied
Seychelles is a developing market for Indian pharmaceuticals — $4.39M in FY 2025–26, with 2.6× growth over the past decade. Medicines accounts for 90% of shipments, with vaccines contributing $33K. The compound annual growth rate since FY2015 stands at 9.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $3.96M (90.2%) Surgical & Hospital Supplies $327K (7.5%) Traditional & Herbal $68K (1.6%) Vaccines $33K (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Seychelles in the RBI overseas direct investment dataset (2011–2026).